6.
Tully M, McMaw L, Adlakha D, Blair N, McAneney J, McAneney H
. The effect of different COVID-19 public health restrictions on mobility: A systematic review. PLoS One. 2021; 16(12):e0260919.
PMC: 8654173.
DOI: 10.1371/journal.pone.0260919.
View
7.
Kraemer M, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone J
. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science. 2021; 373(6557):889-895.
PMC: 9269003.
DOI: 10.1126/science.abj0113.
View
8.
Landier J, Bassez L, Bendiane M, Chaud P, Franke F, Nauleau S
. Social deprivation and SARS-CoV-2 testing: a population-based analysis in a highly contrasted southern France region. Front Public Health. 2023; 11:1162711.
PMC: 10213643.
DOI: 10.3389/fpubh.2023.1162711.
View
9.
Knock E, Whittles L, Lees J, Perez-Guzman P, Verity R, FitzJohn R
. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Sci Transl Med. 2021; 13(602).
PMC: 8432953.
DOI: 10.1126/scitranslmed.abg4262.
View
10.
Kontopantelis E, Mamas M, Webb R, Castro A, Rutter M, Gale C
. Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry study. Lancet Reg Health Eur. 2021; 7:100144.
PMC: 8454637.
DOI: 10.1016/j.lanepe.2021.100144.
View
11.
Perez-Guzman P, Knock E, Imai N, Rawson T, Santoni C, Elmaci Y
. Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England. Nat Commun. 2023; 14(1):8099.
PMC: 10703916.
DOI: 10.1038/s41467-023-44062-9.
View
12.
Imai N, Rawson T, Knock E, Sonabend R, Elmaci Y, Perez-Guzman P
. Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study. Lancet Public Health. 2023; 8(3):e174-e183.
PMC: 9910835.
DOI: 10.1016/S2468-2667(22)00337-1.
View
13.
Morrissey K, Spooner F, Salter J, Shaddick G
. Area level deprivation and monthly COVID-19 cases: The impact of government policy in England. Soc Sci Med. 2021; 289:114413.
PMC: 8459718.
DOI: 10.1016/j.socscimed.2021.114413.
View
14.
Ward H, Atchison C, Whitaker M, Ainslie K, Elliott J, Okell L
. SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021; 12(1):905.
PMC: 7876103.
DOI: 10.1038/s41467-021-21237-w.
View
15.
Ilin C, Annan-Phan S, Tai X, Mehra S, Hsiang S, Blumenstock J
. Public mobility data enables COVID-19 forecasting and management at local and global scales. Sci Rep. 2021; 11(1):13531.
PMC: 8241991.
DOI: 10.1038/s41598-021-92892-8.
View
16.
Elson R, Davies T, Lake I, Vivancos R, Blomquist P, Charlett A
. The spatio-temporal distribution of COVID-19 infection in England between January and June 2020. Epidemiol Infect. 2021; 149:e73.
PMC: 7985908.
DOI: 10.1017/S0950268821000534.
View
17.
Mathur R, Rentsch C, Morton C, Hulme W, Schultze A, Mackenna B
. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021; 397(10286):1711-1724.
PMC: 8087292.
DOI: 10.1016/S0140-6736(21)00634-6.
View
18.
Smith J, Hopkins S, Turner C, Dack K, Trelfa A, Peh J
. Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England. Epidemiol Infect. 2022; 150:e42.
PMC: 9058658.
DOI: 10.1017/S0950268822000188.
View
19.
Rohleder S, Costa D, Bozorgmehr P
. Area-level socioeconomic deprivation, non-national residency, and Covid-19 incidence: A longitudinal spatiotemporal analysis in Germany. EClinicalMedicine. 2022; 49:101485.
PMC: 9189383.
DOI: 10.1016/j.eclinm.2022.101485.
View
20.
Irizar P, Pan D, Kapadia D, Becares L, Sze S, Taylor H
. Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants. EClinicalMedicine. 2023; 57:101877.
PMC: 9986034.
DOI: 10.1016/j.eclinm.2023.101877.
View